LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
BT-20 GSK1059615
10.0
uM
LJP5
 72
hr
 1657 772 5505 0.1403 -0.2300
BT-20 GSK1059615
10.0
uM
LJP6
 72
hr
 1657 837 5505 0.1520 -0.2133
BT-20 GSK1904529A
10.0
uM
LJP6
 72
hr
 1657 5435 5505 0.9872 0.9816
BT-20 Omipalisib
10.0
uM
LJP6
 72
hr
 1657 1130 5505 0.2053 -0.1371
BT-20 GSK 690693
10.0
uM
LJP5
 72
hr
 1657 3072 5505 0.5581 0.3677
BT-20 GW843682X
10.0
uM
LJP6
 72
hr
 1657 1730 5505 0.3142 0.0188
BT-20 HG-5-113-01
10.0
uM
LJP5
 72
hr
 1657 1376 5505 0.2500 -0.0731
BT-20 HG-5-88-01
10.0
uM
LJP6
 72
hr
 1657 3006 5505 0.5461 0.3506
BT-20 Imatinib
10.0
uM
LJP6
 72
hr
 1657 5268 5505 0.9570 0.9384
BT-20 JNK-9L
10.0
uM
LJP6
 72
hr
 1657 1246 5505 0.2264 -0.1068
BT-20 JW-7-24-1
10.0
uM
LJP6
 72
hr
 1657 1813 5505 0.3294 0.0405
BT-20 Lapatinib
10.0
uM
LJP6
 72
hr
 1657 4252 5505 0.7724 0.6744
BT-20 LDN-193189
10.0
uM
LJP5
 72
hr
 1657 545 5505 0.0991 -0.2890
BT-20 Linifanib
10.0
uM
LJP6
 72
hr
 1657 2877 5505 0.5227 0.3170
BT-20 Linsitinib
10.0
uM
LJP5
 72
hr
 1657 4391 5505 0.7976 0.7104
BT-20 Mitoxantrone
10.0
uM
LJP5
 72
hr
 1657 1047 5505 0.1902 -0.1587
BT-20 Mitoxantrone
10.0
uM
LJP6
 72
hr
 1657 924 5505 0.1679 -0.1906
BT-20 MK2206
10.0
uM
LJP6
 72
hr
 1657 1838 5505 0.3340 0.0470
BT-20 Neratinib
10.0
uM
LJP5
 72
hr
 1657 2883 5505 0.5238 0.3186
BT-20 Nilotinib
10.0
uM
LJP5
 72
hr
 1657 2060 5505 0.3742 0.1045
BT-20 Nintedanib
10.0
uM
LJP6
 72
hr
 1657 3332 5505 0.6053 0.4352
BT-20 NU7441
10.0
uM
LJP5
 72
hr
 1657 2467 5505 0.4481 0.2103
BT-20 Dactolisib
10.0
uM
LJP5
 72
hr
 1657 1976 5505 0.3590 0.0829
BT-20 NVP-TAE684
10.0
uM
LJP6
 72
hr
 1657 1604 5505 0.2915 -0.0138
BT-20 Palbociclib
10.0
uM
LJP6
 72
hr
 1657 2337 5505 0.4246 0.1767